GlassScriptPhysician profile
Adam A Lyko
NPI 1659485332
$5,238.65
in general payments reported to CMS, 2019-2025
14 companies · $1,504 in 2025
The $1,504 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $2,250 · 2021: $189 · 2022: $18.83 · 2023: $528 · 2024: $441 · 2025: $1,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,473.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $2,550.38 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $486.14 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Beta Bionics, INC. | $381.87 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ascendis Pharma Endocrinology INC | $333.20 | 2023-2025 | |
| Amgen INC. | $306.81 | 2021-2025 | Evenity, Tepezza |
| Medtronic, INC. | $285.06 | 2023-2025 | Minimed 780g |
| Sequel Med Tech, LLC | $230.56 | 2025 | Twiist |
| Insulet Corporation | $150.31 | 2021-2025 | Omnipod |
| Alexion Pharmaceuticals, INC. | $147.49 | 2019-2024 | Strensiq |
| Shire North American Group INC | $124.68 | 2019 | |
| Radius Health, INC. | $115.42 | 2024 | Tymlos |
| Kyowa Kirin, INC. | $59.95 | 2024 | |
| Dexcom, INC. | $43.54 | 2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $23.24 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Lyko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.